Research Projects & Grants

College/University

  • A Multicenter, Randomized Trial of Preterm Infants receiving Caffeine and Less Invasive Surfactant Administration Compared to Caffeine and Early Continuous Positive Airway Pressure (CaLI Trial), Role: PI, Sharp Mary Birch Hospital for Women and Newborns, (07/2024 - 07/2025) Status: Approved
  • Brain Oxygenation - II, Role: Investigator, Washington University School of Medicine in St. Louis, (07/2022 - 06/2024) Status: Completed

Federal

  • Premature infants receiving milking or delayed cord clamping: Randomized controlled multicenter non-inferiority trial, Role: Investigator, National Institute of Child Health and Human Development/NIH/DHHS, (12/2024 - 12/2025) Status: Approved

Foreign

  • Safeguarding the brain of our smallest children - An investigator-initiated, pragmatic, open-label, multinational randomized phase III clinical trial evaluating treatment based on near-infrared spectroscopy monitoring versus treatment as usual in premature infants, Role: Investigator, Region Hovedstaden, (08/2021 - 08/2022) Status: Completed

Internal

  • Oxidative stress, DNA methylation, gene endothelial biology, and gene expression in the human placenta, Role: Investigator, LLU Dept. of Gynecology & Obstetrics, (08/2024 - 08/2025) Status: Approved
  • SafeBoosC III two-year follow-up (Safeguarding the Brain of our smallest Children). Cerebral near-infrared spectroscopy monitoring versus treatment as usual for extremely preterm infants: a protocol for the follow-up study for the SafeBoosC-III trial, Role: Investigator, LLU Dept. of Pediatrics, (04/2023) Status: Approved
  • Evaluation of Resource Utilization, Risk, and Benefit of Corticosteroid Administration in Pregnancy, Role: Investigator, LLU Dept. of Gynecology & Obstetrics, (12/2020) Status: Approved
  • Molecular markers of steroid sensitivity in fetal immune and endothelial cells, Role: Other Significant Contributor, LLU - GRASP, (01/2020 - 06/2025) Status: Awarded

Other Research

  • Site Investigator – extra mural project CaLI, Caffeine and Less Invasive Surfactant an investigator-initiated, open-label, multicenter regional randomized phase III clinical trial evaluating the use of an angiocatheter in comparison to endotracheal tube delivery of surfactant. PI Anup Katheria, Sharp Mary Birch Women and Children’s Hospital (06/2020 - 02/2023)
  • Research mentor-Vanderbilt University Medical Center Department of Pathology Name of project: Effect of the Innate Immune System on Mediating Transfusion Related Immunomodulation (TRIM)                                                        Grant Support:  5T32HD068256 Preventing Prematurity and Poor Pregnancy Outcomes Training Grant (PI: Reese); Department of Pathology, Microbiology and Immunology Clinical and Translational Research Enhancement Award (01/2013 - 02/2023)
  • Site Investigator   extra mural project SafeBoosC-III, an investigator-initiated, pragmatic, open label,  multinational randomized phase III clinical trial evaluating treatment based on near-infrared spectroscopy monitoring versus treatment as usual in premature infants Copenhagen Trial  Unit number: SafeBoosC-DP-363  PI Jonathan Mintzer, Stonybrook Childrens’ Hospital Nov 2018 - 2022 (11/2018 - 03/2022)